Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| INVIVYD | 7 | 3 | 0,00 % | ||
| BIONTECH | 6 | 13 | 0,00 % | ||
| SAVARA | 4 | - | -0,91 % | ||
| REGENERON PHARMACEUTICALS | 3 | 22 | +0,33 % | ||
| NEUROCRINE BIOSCIENCES | 3 | 17 | -0,32 % | ||
| AGIOS | 3 | 8 | -0,95 % | ||
| IRONWOOD PHARMACEUTICALS | 3 | - | +2,21 % | ||
| MIND MEDICINE | 3 | - | -1,09 % | ||
| DYNE THERAPEUTICS | 3 | - | 0,00 % | ||
| ATAI BECKLEY | 3 | - | +0,63 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02:29 | FDA Approves Agios' AQVESME For Treatment Of Anemia In Alpha- And Beta-Thalassemia | 2 | RTTNews | ||
| 02:18 | Cathie Wood's ARK buys Weride, Pacific Biosciences stocks, sells Ibotta | 1 | Investing.com | ||
| 02:10 | Mesoblast, Invictus, PLS Group, more: The 10 stocks that got investor chins wagging on HotCopper in CY25 | 2 | The Market Herald Australia | ||
| 02:06 | FDA approves Agios' AQVESME for thalassemia anemia treatment | 2 | Investing.com | ||
| 01:48 | Agios Pharmaceuticals, Inc.: U.S. FDA Approves Agios' AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia | 1 | GlobeNewswire (USA) | ||
| 01:29 | Zai Lab Receives Approval In China For Schizophrenia Drug COBENFY | 2 | RTTNews | ||
| Di | Janux completes phase 1a dose-escalation for EGFR cancer drug | 1 | Investing.com | ||
| Di | Janux schließt Phase-1a-Dosiseskalation für EGFR-Krebsmedikament ab | 5 | Investing.com Deutsch | ||
| Di | Vor Biopharma: Vor Bio Appoints RA Capital's Andrew Levin, M.D., Ph.D., and Forbion's Wouter Joustra to Board of Directors | 1 | GlobeNewswire (USA) | ||
| Di | Krystal Biotech, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Di | Why CorMedix Could be the Biopharma Name to Watch Early in 2026 | 2 | MarketBeat | ||
| Di | BioMarin To Buy Amicus For $4.8 Billion | 2 | pulse2.com | ||
| Di | Is This the Right Time to Add Veracyte Stock to Your Portfolio? | 1 | Zacks | ||
| Di | Biontech-Aktie zeigt auffällige Dynamik: Investoren beobachten nervös - brandneue Entwicklung! | Hebelschein-Spekulant | |||
| Di | What's Going On With BioMarin Stock On Tuesday? | 1 | Benzinga.com | ||
| Di | Sanofi Wins EU Approval For Wayrilz In Immune Thrombocytopenia | 253 | AFX News | PARIS (dpa-AFX) - Sanofi SA (SNY) on Tuesday said that the European Commission has given the green light to Wayrilz or rilzabrutinib for treating immune thrombocytopenia in adults who haven't... ► Artikel lesen | |
| Di | Neurocrine's Ingrezza fails phase 3 trial for cerebral palsy | 2 | FiercePharma | ||
| Di | Eilmeldung am Abend: BIONTECH SE ADR wirkt still vor dem Sturm | 115 | Maximilian Berger | ||
| Di | GILD Exercises Option to License Assembly Bio's Herpes Programs | 49 | Zacks | ||
| Di | ABBV vs. AZN: Which Pharma Stock is the Better Investment Now? | 6 | Zacks |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .